A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 1	2025-12-19		NCT04550104

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beatson West of Scotland Cancer Centre	4
Newcastle University	32
Queen's University, Belfast	29
The Leeds Teaching Hospitals NHS Trust	36
University College London Hospitals	51
University of Glasgow	73
University of Leeds	70
University of Manchester	85
University of Oxford	213
University of Sheffield	43
Velindre NHS Trust	4

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Addenbrooke's Hospital	Cambridge	United Kingdom	26
Belfast City Hospital	Belfast	United Kingdom	13
Birmingham Heartlands Hospital	Birmingham	United Kingdom	11
Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust	Newcastle upon Tyne	United Kingdom	1
St Bartholomew's Hospitals	London	United Kingdom	1
St James's University Hospital	Leeds	United Kingdom	16
The Christie NHS Foundation Trust	Manchester	United Kingdom	40
The Clatterbridge Cancer Centre	Liverpool	United Kingdom	2
The Royal Marsden Hospital Chelsea	Chelsea	United Kingdom	1
The Royal Marsden Sutton	Sutton	United Kingdom	1
University College Hospital London	London	United Kingdom	1
Velindre Cancer Centre	Cardiff	United Kingdom	12
Western General Hospital	Edinburgh	United Kingdom	23
Weston Park Hospital	Sheffield	United Kingdom	12